Chapter 4 : Membrane bioreactors for bio-artificial pancreas - Université de technologie de Compiègne Access content directly
Book Sections Year : 2020

Chapter 4 : Membrane bioreactors for bio-artificial pancreas


Designing an efficient and functional bioartificial pancreas (BAP) at human scale to treat type I diabetes remains the Holy Grail in the 2010s, although investigations started in the 1970s. Biomimetic approaches need to be performed and evaluated to offer insulin secreting cells an environment close to the native pancreas, but also accounting for the interactions between the pancreas and other organs, and more specifically liver. This chapter outlines the concept, development and recent progress of BAP technology, with specific focus on interaction between BAP and the host environment. After the introduction of pancreas anatomy and physiology and the current treatments for diabetic patients, we will study how fulfill (or not) the requirements for an efficient BAP, regarding its different components: cell types, encapsulation methods, membranes and devices dedicated to several implantation sites. We conclude with a short discussion of future directions including BAP revascularization to improve the exchanges with the host and the impact of microtechnologies on the development of next generation of BAP.


Fichier principal
Vignette du fichier
CH0004_Legallais_soumis.pdf (1.3 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04476956 , version 1 (27-02-2024)



Rachid Jellali, Amal Essaouiba, Eric Leclerc, Cécile Legallais. Chapter 4 : Membrane bioreactors for bio-artificial pancreas. Current Trends and Future Developments on (Bio-) Membranes, Elsevier, pp.77-108, 2020, ⟨10.1016/b978-0-12-814225-7.00004-8⟩. ⟨hal-04476956⟩
41 View
16 Download



Gmail Mastodon Facebook X LinkedIn More